Rheumatoid Arthritis Clinical Trials in Chicago

Showing 1741-1760 of 3,348 trials

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

NCT03995901

A randomized controlled study to evaluate the safety, efficacy, and overall benefit of FCR001 cell therapy in de novo living donor renal transplantation.

Transplanted Organ Rejection

Talaris Therapeutics Inc.15 participantsStarted Oct 2019

Phoenix, Arizona, United States • La Jolla, California, United States • San Francisco, California, United States +15 more locations

WITHDRAWNPhase 22.2 miles

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

NCT01649388

An open-label study to assess the safety, tolerability, and efficacy of FCR001 cell therapy in adult recipients 3-12 months after kidney transplantation from a living donor.

Kidney Transplantation

Talaris Therapeutics Inc.Started Oct 2012

Washington D.C., District of Columbia, United States • Chicago, Illinois, United States • Minneapolis, Minnesota, United States

A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

A Safety and Efficacy Study of FCR001 Cell Therapy in Previously Transplanted Living Donor Kidney Recipients

Rheumatoid Arthritis Trials in Other Cities

Written Versus Verbal Brief Cognitive Behavioral Exposure Therapy

Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine

Expanded Access Protocol Using 131I-MIBG

Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial

Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19

Trial in Adult Subjects With Acute Migraines

A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM)

Safety and Efficacy in Adult Subjects With Acute Migraines

Study of the Safety and Efficacy of APX3330 in Diabetic Retinopathy

Post-Market Registry of AURYON™ Atherectomy Device in Subjects Affected With Infrainguinal Peripheral Artery Disease

Characterization & Treatment of Chronic Pain After Moderate to Severe TBI

Study of the Safety and Efficacy of OPC-34712 as a Complementary Therapy in the Treatment of Adult Attention Deficit/Hyperactivity Disorder

Bacteriophage Therapy in Patients With Urinary Tract Infections

Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer

Safety, Tolerability, and Pharmacokinetics of Oral NX-13 in Active Ulcerative Colitis

Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study

Study to Evaluate Safety and Pharmacokinetics of BIVIGAM® in Primary Immune Deficiency Subjects Aged 2 to 16

Thoracolumbar Burst Fractures Study Comparing Surgical Versus Non-surgical Treatment

Other Conditions in Chicago